Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
Information source: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cutaneous T Cell Lymphoma; Graft Versus Host Disease
Phase: N/A
Status: Recruiting
Sponsored by: Dartmouth-Hitchcock Medical Center Official(s) and/or principal investigator(s): Frederick Lansigan, MD, Principal Investigator, Affiliation: Dartmouth-Hitchcock Medical Center
Overall contact: Frederick Lansigan, MD, Phone: 800-639-6918, Email: Cancer.Research.Nurse@Dartmouth.edu
Summary
Extracorporeal Photopheresis (ECP) is a form of apheresis and photodynamic therapy in which
the peripheral blood is treated with 8-methoxypsoralen, which is then activated with UV
light. ECP is currently a standard therapy for cutaneous T-cell lymphoma (CTCL) and is also
effective for graft-versus-host disease (GVHD). The investigators would like to study the
outcomes (response rates) of patients receiving ECP treatment and other factors relating to
their disease and treatment, as well as procedural events, such as complications.
Clinical Details
Official title: Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis
Study design: Observational Model: Case-Only, Time Perspective: Prospective
Primary outcome: Response rates
Secondary outcome: Complications
Detailed description:
The investigators intend to report outcomes from the inception of this procedure at
Dartmouth-Hitchcock Medical Center (DHMC) in May 2008 through 9/30/11. Additionally, the
investigators would like to maintain a prospective database of these patients so that new
patient data can be collected for updating of outcomes.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients who receive Extracorporeal Photopheresis treatment
- Treated at Dartmouth-Hitchcock Medical Center
- Must be 18 years or older
Locations and Contacts
Frederick Lansigan, MD, Phone: 800-639-6918, Email: Cancer.Research.Nurse@Dartmouth.edu
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, United States; Recruiting Frederick Lansigan, MD, Phone: 800-639-6918, Email: Cancer.Research.Nurse@Dartmouth.edu Frederick Lansigan, MD, Principal Investigator
Additional Information
Starting date: October 2011
Last updated: May 8, 2015
|